ISEC Healthcare Ltd. (SGX:40T)

ISEC Healthcare Financials Overview

Financials in millions SGD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	79.97	79.21	74.2	69.99	62.95	40.47
Revenue Growth	6.42%	6.76%	6.00%	11.18%	55.56%	11.40%
Gross Profit Gross Profit Growth	33.08	33.36	32.67	31.04	28.77	17.88
Operating Income Operating Income Growth	17.2	17.52	18.11	18.23	16.88	8.69
Net Income Net Income Growth	13.12	13.37	12.82	12.96	12.52	6.91
Earnings Per Share EPS Growth	0.02	0.02	0.02	0.02	0.02	0.01
EPS Growth	2.76%	4.04%	-1.33%	1.80%	77.60%	45.93%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Specialised Health Services Specialised Health Services Growth	75.34	70.6	66.02	58.51	36.77
General Health Services General Health Services Growth	3.87	3.6	3.98	4.44	3.7
Total Total Growth	79.21	74.2	69.99	62.95	40.47

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	22.71	24.76	16.52	20.02	20.63	23.01
Total Debt Total Debt Growth	27.03	27.06	13.09	12.56	13.82	9.87
Net Cash (Debt) Net Cash Growth	-4.33	-2.3	3.43	7.46	6.82	13.14
Net Cash Growth	-	-	-53.97%	9.41%	-48.15%	-14.47%
Net Cash Per Share Net Cash Per Share Growth	-0.01	-0.00	0.01	0.01	0.01	0.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	16.19	18.97	17.64	17.17	17.85	12.3
Capital Expenditures CapEx Growth	-19.59	-19.55	-11.78	-3.42	-5.71	-0.73
Free Cash Flow Free Cash Flow Growth	-3.4	-0.57	5.86	13.75	12.14	11.57
Free Cash Flow Growth	-	-	-57.38%	13.33%	4.91%	108.04%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	41.36%	42.12%	44.03%	44.34%	45.70%	44.18%
Operating Margin	21.50%	22.12%	24.40%	26.04%	26.82%	21.48%
Pretax Margin	21.67%	22.35%	23.16%	24.74%	26.65%	22.45%
Profit Margin	16.40%	16.88%	17.28%	18.52%	19.89%	17.06%
FCF Margin	-4.25%	-0.73%	7.90%	19.65%	19.28%	28.58%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.006	0.006	0.010	0.016	0.016	0.011
Dividend Per Share Growth	-42.00%	-42.00%	-37.89%	3.21%	48.57%	31.25%
Dividend Yield	2.00%	1.88%	2.60%	3.71%	5.58%	3.86%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	12.74	13.57	17.94	20.61	14.40	25.11
Forward PE	-	18.53	18.53	18.53	18.53	18.53
P/FCF Ratio	-	-	39.26	19.42	14.85	14.99
PS Ratio	2.09	2.29	3.10	3.82	2.86	4.28

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error